Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sernova Biotherapeutics Inc
(OP:
SEOVF
)
0.1148
-0.0037 (-3.12%)
Streaming Delayed Price
Updated: 3:25 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,650
Open
0.1098
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1185
Today's Range
0.1098 - 0.1148
52wk Range
0.1057 - 0.1837
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sernova Announces Key New Executive Appointments
October 11, 2024
Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs.
Via
TheNewswire.com
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
October 03, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Performance
YTD
-26.2%
-26.2%
1 Month
-14.1%
-14.1%
3 Month
-23.6%
-23.6%
6 Month
-20.8%
-20.8%
1 Year
-30.4%
-30.4%
More News
Read More
Sernova Provides Positive Clinical and Platform Portfolio Update
April 02, 2024
Via
TheNewswire.com
Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy of a Novel Cell Pouch Cell Therapy Approach for Treatment of Severe Hemophilia A
January 20, 2022
Via
TheNewswire.com
Sernova to Present Corporate Update at Canaccord Genuity's 41st Annual Growth Conference
August 09, 2021
Via
TheNewswire.com
Sernova Announces 2021 Annual Meeting Results: Shareholders Approve Resolutions with Overwhelming Majority
July 05, 2021
Via
TheNewswire.com
Industry Veteran Frank Shannon Joins Sernova as VP Clinical Development and Regulatory Affairs
June 30, 2021
Via
TheNewswire.com
Sernova's Principal Investigator Presents Interim Data and Positive Patient Outcomes of Phase I/II T1D Study at the American Diabetes Association 81st Scientific Sessions
June 28, 2021
Via
TheNewswire.com
Sernova's Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference
June 07, 2021
Via
TheNewswire.com
Sernova Announces American Transplant Congress 2021 Virtual Connect Abstract Presentation
June 01, 2021
Via
TheNewswire.com
Sernova to Present at Global Partnership Family Office -- HealthCare & Biotechnology TSX Showcase
May 17, 2021
Via
TheNewswire.com
Sernova Announces the Nomination of Seasoned Pharma Executive Dr. Mohammad Azab to its Board of Directors
May 04, 2021
Via
TheNewswire.com
Topics
Retirement
Sernova KOL Event Highlights Novel Cell Therapy Approach for the Potential Treatment of Thyroid Disease
April 28, 2021
Via
TheNewswire.com
Sernova to Host a Virtual Key Opinion Leader Event on Thyroid Disease and the Potential for its Cell Therapy as a Novel Treatment Approach
April 21, 2021
Via
TheNewswire.com
Sernova Appoints Internationally Renowned Thyroid Disease Expert Dr. Sam Wiseman to its Scientific Advisory Board
April 14, 2021
Via
TheNewswire.com
Frequently Asked Questions
Is Sernova Biotherapeutics Inc publicly traded?
Yes, Sernova Biotherapeutics Inc is publicly traded.
What exchange does Sernova Biotherapeutics Inc trade on?
Sernova Biotherapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sernova Biotherapeutics Inc?
The ticker symbol for Sernova Biotherapeutics Inc is SEOVF on the OTC Traded
What is the current price of Sernova Biotherapeutics Inc?
The current price of Sernova Biotherapeutics Inc is 0.1148
When was Sernova Biotherapeutics Inc last traded?
The last trade of Sernova Biotherapeutics Inc was at 10/27/25 03:25 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.